Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Retraction

Retraction: Targeting 3-Phosphoinoside-Dependent Kinase-1 to Inhibit Insulin-Like Growth Factor-I Induced AKT and p70 S6 Kinase Activation in Breast Cancer Cells

  • The PLOS ONE Editors
  • Article
  • Metrics
  • Comments
  • Media Coverage

The author Sangita Baxi and a Pfizer representative contacted the editorial office to raise that there are image duplications in this article. Pfizer has undertaken a review and determined that there are duplications in Fig 1 and Fig 2 of the article and that part of the experiments cannot be verified.

In light of the concerns identified, the authors and the PLOS ONE Editors retract this article. We did not receive any response or comment from Min-Jean Yin, Wei Tan, or Tod Smeal.

Reference

  1. 1. Baxi SM, Tan W, Murphy ST, Smeal T, Yin M-J (2012) Targeting 3-Phosphoinoside-Dependent Kinase-1 to Inhibit Insulin-Like Growth Factor-I Induced AKT and p70 S6 Kinase Activation in Breast Cancer Cells. PLoS ONE 7(10): e48402. pmid:23119004

Citation: The PLOS ONE Editors (2017) Retraction: Targeting 3-Phosphoinoside-Dependent Kinase-1 to Inhibit Insulin-Like Growth Factor-I Induced AKT and p70 S6 Kinase Activation in Breast Cancer Cells. PLoS ONE 12(4): e0175772. https://doi.org/10.1371/journal.pone.0175772

Published: April 10, 2017

Copyright: © 2017 The PLOS ONE Editors. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.